Ospemifene for vulvar and vaginal atrophy: an overview

Santiago Palacios MD, PhD

Article Type



This editorial article introduces a Special Focus Issue entitled “Treatment of Vulvar and Vaginal Atrophy: Clinical Experience with Ospemifene”. Ospemifene is a selective estrogen receptor modulator indicated for treatment of moderate-to-severe symptomatic vulvar and vaginal atrophy in postmenopausal women who are not candidates for local vaginal estrogen therapy or have contraindications for estrogen products.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.